Nazir Shaheen, Khan Waseem A, Jan Zubair, Sulayman Shahid, Gulzar G M, Sodi Jaswinder S
Department of Gastroenterology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, IND.
Cureus. 2025 Jun 29;17(6):e86956. doi: 10.7759/cureus.86956. eCollection 2025 Jun.
Biliary tract diseases place a significant burden on healthcare in Kashmir. Endoscopic retrograde cholangiopancreatography (ERCP) is the gold standard for managing common bile duct stones (CBDS). However, challenging CBDS present considerable obstacles and complicate patient care, highlighting the necessity for specialized expertise and collaborative approaches. This study evaluates the effectiveness and safety of ERCP in treating CBDS, particularly focusing on difficult-to-manage cases, at a tertiary care center in the Kashmir region of North India. Objective: This study aimed to investigate the therapeutic outcomes and safety profile of ERCP in CBDS management, emphasizing exploring optimal strategies and modalities for successfully removing complex and difficult-to-treat stones. Methods: A retrospective study was conducted on ERCPs performed between March 2024 and March 2025 at Sher-i-Kashmir Institute of Medical Sciences (SKIMS) in Srinagar, Kashmir, India. The efficacy of ERCP in clearing CBDS was assessed, and complications were noted. Patients with large (≥1.5 cm) stones of difficult morphology, such as barrel or square-shaped, or those with hard consistency, or those associated with stricture/narrowing seen on prior imaging or cholangiogram were classified as having "difficult" stones. A retrospective review of medical records analyzed patients with CBDS who underwent ERCP, evaluating procedure success, complications, and outcomes, with a focus on effectiveness in difficult CBD.
The study achieved an overall CBDS clearance rate of 650/682 (95.3%), with a clearance rate of 160/190 (84.2%) for difficult stones. For difficult stones, endoscopic papillary large balloon dilation (EPLBD) alone was successful in 117/190 (61.5%) cases. Additional interventions, including mechanical lithotripsy (ML) in 18/190 (9.4%) cases, extracorporeal shock wave lithotripsy (ESWL) in 13/190 (6.8%) cases, and electrohydraulic lithotripsy (EHL) in 12/190 (6.3%) cases, were required. The overall success rates for these interventions were as follows: EPLBD 117/175 (66.8%), ML 18/30 (60%), ESWL 13/20 (65%), and EHL 12/13 (92.3%). Surgical intervention was required in 30/190 (15.7%) cases. Complications occurred in 82 (12%) of overall cases and 13 (6.8%) of difficult stone cases.
In conclusion, our findings underscore the value of ERCP in managing CBDS, particularly challenging ones, with high efficacy and an acceptable safety profile. This supports its continued use as a primary treatment option for complex CBDS. While complications related to ERCP do occur, they are primarily associated with sphincterotomy/precut procedures for gaining access to the CBD. Notably, managing difficult stones does not appear to increase the complication rate, further strengthening ERCP's role in the treatment of complex biliary cases.
胆道疾病给克什米尔地区的医疗保健带来了沉重负担。内镜逆行胰胆管造影术(ERCP)是治疗胆总管结石(CBDS)的金标准。然而,具有挑战性的胆总管结石带来了相当大的障碍,并使患者护理复杂化,凸显了专业知识和协作方法的必要性。本研究评估了在印度北部克什米尔地区的一家三级医疗中心,ERCP治疗CBDS的有效性和安全性,特别关注难以处理的病例。
本研究旨在调查ERCP在CBDS管理中的治疗效果和安全性,重点探索成功清除复杂和难以治疗的结石的最佳策略和方式。
对2024年3月至2025年3月在印度克什米尔斯利那加的谢里 - 克什米尔医学科学研究所(SKIMS)进行的ERCP手术进行回顾性研究。评估ERCP清除CBDS的疗效,并记录并发症。结石较大(≥1.5 cm)、形态困难(如桶状或方形)、质地坚硬,或在先前影像学检查或胆管造影中发现伴有狭窄/缩窄的患者被归类为患有“困难”结石。对接受ERCP的CBDS患者的病历进行回顾性分析,评估手术成功率、并发症和治疗结果,重点关注在困难胆总管结石治疗中的有效性。
该研究的总体CBDS清除率为650/682(95.3%),困难结石的清除率为160/190(84.2%)。对于困难结石,单纯内镜乳头大球囊扩张术(EPLBD)在117/190(61.5%)的病例中成功。还需要额外的干预措施,包括18/190(9.4%)的病例采用机械碎石术(ML)、13/190(6.8%)的病例采用体外冲击波碎石术(ESWL)以及12/190(6.3%)的病例采用电液压碎石术(EHL)。这些干预措施的总体成功率如下:EPLBD为117/175(66.8%),ML为18/30(60%),ESWL为13/20(65%),EHL为12/13(92.3%)。30/190(15.7%)的病例需要手术干预。总体病例中有82例(12%)发生并发症,困难结石病例中有13例(6.8%)发生并发症。
总之,我们的研究结果强调了ERCP在管理CBDS,特别是具有挑战性的CBDS方面的价值,其具有高疗效和可接受的安全性。这支持其继续作为复杂CBDS的主要治疗选择。虽然与ERCP相关的并发症确实会发生,但它们主要与为进入胆总管而进行的括约肌切开术/预切开手术有关。值得注意的是,处理困难结石似乎并未增加并发症发生率,这进一步强化了ERCP在复杂胆道病例治疗中的作用。